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Antimicrobial activityNew organotin(IV) complexes of 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine (dbtp) and 5,7-diphenyl-
1,2,4-triazolo[1,5-a]pyrimidine (dptp) with 1:1 and/or 1:2 stoichiometry were synthesized and investigated
by X-ray diffraction, FT-IR and 119Sn Mössbauer in the solid state and by 1H and 13C NMR spectroscopy, in so-
lution. Moreover, the crystal and molecular structures of Et2SnCl2(dbtp)2 and Ph2SnCl2(EtOH)2(dptp)2 are
reported. The complexes contain hexacoordinated tin atoms: in Et2SnCl2(dbtp)2 two 5,7-ditertbutyl-1,2,4-
triazolo[1,5-a]pyrimidine molecules coordinate classically the tin atom through N(3) atom and the coordina-
tion around the tin atom shows a skew trapezoidal structure with axial ethyl groups. In Ph2SnCl2(EtOH)2
(dptp)2 two ethanol molecules coordinate tin through the oxygen atom and the 5,7-diphenyl-1,2,4-triazolo
[1,5-a]pyrimidine molecules are not directly bound to the metal center but strictly H-bonded, through N
(3), to the \OH group of the ethanol moieties; Ph2SnCl2(EtOH)2(dptp)2 has an all-trans structure and the
C–Sn–C fragment is linear. On the basis of Mössbauer data, the 1:2 diorganotin(IV) complexes are advanced
to have the same structure of Et2SnCl2(dbtp)2, while Me2SnCl2(dptp)2 to have a regular all-trans octahedral
structure. A distorted cis-R2 trigonal bipyramidal structure is assigned to 1:1 diorganotin(IV) complexes. The
in vitro antibacterial activities of the synthesized complexes have been tested against a group of reference
pathogen micro-organisms and some of them resulted active with MIC values of 5 μg/mL, most of all against
staphylococcal strains, which shows their inhibitory effect.+39 091 427584.
solo).
rights reserved.© 2011 Elsevier Inc. All rights reserved.1. Introduction
Triazolopyrimidine derivatives are well known N-donor heterocy-
clic ligands [1,2]; the steric effects of substituents in these ligands are in-
teresting and have not been explored in great details for organotins,
especially for those ligands bearing substituents at positions 5 and 7,
while triazolopyrimidine and its derivatives have gained great attention
as ligands to transition metals [3–6]. Our interest was recently devoted
to organotin(IV) complexes of [1,2,4] triazolo-[1,5-a]pyrimidine (tp), its
5,7-dimethyl derivative (dmtp) and a number of oxo-substituted tria-
zolopyrimidines whose antimicrobial activity was excellent [7–9]. This
promising ﬁnding was suggesting a possible use of triazolopyrimidines
derivatives as leads for a potentialﬁeld of novel therapeutic options able
to overcome the antibiotic resistant strains which prompted us to un-
dertake the present study by evaluating the change of activity associated
with the introduction on the basic heterocycle of different radical
groups giving non classical isosteric ligands, expected to be endowedwith better hydrophobicity. Besides, organotins are known to possess,
per se, antitumour [10,11], antimicrobial [12] and anti-inﬂammatory
[13] activities; triazolopyrimidines complexes with several divalent
metal ions have been tested as inhibitors of the growth of different
Gram(+) and Gram(−) bacteria [12]. In particular, recent ﬁndings on
compounds of metal ions (Co(II), Cu(II), Ni(II)) with closely related li-
gands, have proven to be effective antiparasital agents against Trypano-
soma cruzi [14] and to be endowedwith antiproliferative in vitro activity
against Leishmania spp. [15]; the biological activity on these specimen is
still in progress [16]. Staphylococci can induce awide spectrum of infec-
tious diseases associatedwith remarkablemorbidity andmortality [17].
Pathogenic staphylococci have also an amazing ability to acquire resis-
tance traits to antibiotics, the rise of community and hospital-acquired
methicillin resistant Staphylococcus aureus (MRSA) being amajor health
problem that has created a pressing need for novel therapeutic options
[18]. The threat of pathogenic bacteria resistant to most or all conven-
tional antibiotics could be faced by developing new antibacterial agents
with a different mode of action than those of traditional antibiotics. In
this paper we report the synthesis and characterization of organotin
(IV) adducts (R2SnCl2, R=Me, Et, n-Bu and Ph and RSnCl3, R=n-Bu)
with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine (dbtp) and 5,7-
Table 1
Crystal data and details of reﬁnement for Et2SnCl2(dbtp)2 (4) and Ph2SnCl2(EtOH)2
(dptp)2(11).
Compound 4 11
Empirical formula C30 H50 Cl2 N8 Sn C50H46Cl2N8O2Sn
Formula weight 712.37 980.54
Temperature (K) 293 K 293 K
Wavelength (Å) 0.71073 0.71073
Crystal system Monoclinic Monoclinic
Space group P21/c I2/a
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1:2 molar ratio. The crystal and molecular structures of Et2SnCl2
(dbtp)2 and Ph2SnCl2(EtOH)2(dptp)2 are also reported and their
metal-to-triazolo pyrimidine ligand interaction is discussed, together
with their overall supramolecular organization.We tested the biological
activity of all the specimen against a group of staphylococcal reference
strains (S. aureus ATCC 25923, S. aureus ATCC 29213, methicillin resistant
S. aureus 43866 and S. epidermidis RP62A) along with Gram-negative
pathogens (P. aeruginosa ATCC9027 and E. coli ATCC25922).
2. Experimental
2.1. Materials and methods
The chemicals used throughout in the present study were pur-
chased from C. Erba (Milan, Italy), Sigma-Aldrich (Milan, Italy), and
Merck KGaA (Germany), and used without further puriﬁcation. Anhy-
drous methanol was obtained by standard procedure. Elemental mi-
croanalyses for C, H and N were carried out by the Laboratorio di
Microanalisi, University of Padova, Italy. Chlorine was determined
by potentiometric titration with standard silver nitrate after combus-
tion in pure oxygen according to Schöniger [19]. Tin was gravimetri-
cally determined as SnO2. Infrared spectra (nujol mulls, CsI windows)
were recorded with an FT-IR spectrometer Perkin-Elmer Spectrum
One. The Mössbauer (nuclear γ resonance) spectrometers, the related
instrumentation and data reduction procedures were as previously
described [20]. A 10 mCi Ca119SnO3 source (RITVERC GmbH, St. Pe-
tersburg, Russia) was employed. The isomer shifts (δ) are relative to
room temperature Ca119SnO3. The 1H and 13C NMR spectra were ac-
quired in CDCl3 solutions at 298 K on a Bruker 300 Avance spectrom-
eter at 300.13 and 75.47 MHz, respectively.
2.2. X-ray crystal determination
Suitable crystals of Ph2SnCl2(EtOH)2(dptp)2 for the X-ray diffrac-
tion studies were grown from ethanol, data collection was made on
a BRUKER AXS SMART 2000 CCD diffractometer using graphite-
monochromated MoKα radiation (λ=0.71073 Å). Data were collect-
ed using 0.3° wide ω scans and a crystal-to-detector distance of
5.0 cm and corrected for absorption empirically using the SADABS
routine [21]. Data collection nominally covered a full sphere of recip-
rocal space with 30 s exposure time per frame. The SAINT [22] pro-
gram was used for analysis of the data reduction and revealed a
monoclinic P21/c space group. The structure was solved by direct
Methods using the SHELXS-97 [23] program and reﬁned on F2 by
full matrix least-squares calculations using the SHELXTL package.
The anisotropy parameters of non-H atoms were reﬁned with the
SHELXL-97 [24] program. All H atoms of ligands were geometricallyFig. 1. The ligand molecules with the atom numbering scheme: R=C(CH3)3 (dbtp)
and R=C6H5 (dptp).included in the reﬁnement, and reﬁned “riding” on their correspond-
ing carbon or oxygen atom, except for the H atom connected to the O
(1) atom, which was found experimentally in a difference Fourier
map after all the “heavy” atoms were located [C–H 0.93 Å and
0.97 Å for aromatic and aliphatic distances; OH 0.82 Å]. Thermal vi-
brations were treated anisotropically. In addition, the reﬁnement
used theta range for data collection between 2.9 and 30.00° and
show ﬁnal R indices R1=0.0375 for 4307 reﬂections with FoN4sig
(Fo) and 0.0540 for all 5469 data, wR2=0.1234, GooF=S=0.758, re-
strained GooF=0.758 for all data.
For Et2SnCl2(dbtp)2, suitable crystals were grown from diethyl
ether; the X-ray diffraction data were collected at 295 K using an Ox-
ford Xcalibur S with Mo–Kα radiation, λ=0.71073 Å, monochroma-
tor graphite for Et2SnCl2(dbtp)2. The cell parameters for the
molecule were obtained and reﬁned, respectively, catching reﬂec-
tions with random orientation in hkl planes. Intensities were cor-
rected by Lorentz polarization and absorption with the SADABS [21]
program. The SAINT [22] program was used for analysis of the data
reduction and revealed a monoclinic P21/c space group. The structure
was solved by direct methods using the SHELXS-97 [23] program. The
anisotropy parameters of non-H atoms were reﬁned with the
SHELXL-97 [24] program. All H atoms of ligands were geometrically
included in the reﬁnement. Aromatic carbons were reﬁned with
Uiso(H)=1.2 Ueq Csp2 and methyl carbons with Uiso(H)=1.5 Ueq
Csp3. In addition, the ﬁnal reﬁnement used the complete theta
range for data collection between 2.9 and 30.00° and shows ﬁnal R in-
dices R1=0.0376 for 2604 reﬂections with FoN4sig(Fo) and 0.0900
for all 4317 data, wR2=0.0800, GooF=S=0.804, restrained
GooF=0.804 for all data. X-ray data are listed in Table 1. ORTEP-3
[25] for Windows was used to draw the ﬁgures while Mercury was
used for the graphical representation of the crystal packings [26].
Analysis of crystal data was performed through PARST [27].
2.3. Antimicrobial activity
2.3.1. Bacterial strains
A group of staphylococcal reference strains, viz. S. aureus ATCC
25923, S. aureus ATCC 29213 and methicillin resistant S. aureusa (Å)
b (Å)
c (Å)
β (°)
17.8248(5)
11.1062(2)
18.4027(5)
101.818(3)
13.4604(6)
7.7689(4)
22.3827(10)
106.4490(10)
Volume (Å3) 3565.88(15) 2244.82(18)
Z 4 2
Density (Mg m−3) 1.327 1.451
F(000) 1480 1004
Crystal size (mm) 0.15×0.30×0.22 0.35×0.20×0.30
θ Range for data collection (°) 2.90–29.50 1.90–28.73
Index range −24≤h≤24
−14≤k≤14,
−24≤ l≤25
−17≤h≤17
−10≤k≤10,
−30≤ l≤29
Reﬂections collected 19553 25299
Data/restraints/parameters 4317/0/178 5469/0/256
Goodness-of-ﬁt on F2 0.804 0.757
Final R indices [IN2σ(I)] R1=0.0376,
wR2=0.0676
R1=0.0375,
wR2=0.1075
Largest diff. peak and hole
(e Å−3)
0.28–0.36 0.51–0.49
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reference strains were also used: Pseudomonas aeruginosa ATCC 9027
and Escherichia coli ATCC 25922.
2.3.2. Determination of MICs
Minimum inhibitory concentrations (MICs) against tested strains
were determined as previously described by a broth dilution micro-
method [28]. A series of solutions with a range of concentrations
from 40 to 0.1 μg/mL (obtained by twofold serial dilution) was made
in Mueller-Hinton broth (Merck) in a 96-well plate. To each well 10 μL
of a bacterial suspension, obtained from a 24 h culture, containing
~106 colony forming units (CFU)/mL were added. The plate was incu-
bated at 37 °C for 24 h. After this time the MIC values were determined
by a microplate reader (ELX 800, Bio-Tek Instruments) as the lowest
concentration of compound whose optical density (OD) at 570 nm,
was comparable to the negative control wells (broth only). Amikacin
was used for comparative and quality control purposes.
2.4. Synthesis of ligands
The ligands dbtp and dptpwere synthesized following the Grodzicki
[29] procedure with some modiﬁcations: in both cases 10 mmol of the
chemicals (3-amino-1,2,4-triazole and 2,2,6,6-tetramethylheptane-3,5-
dione or 1,3-diphenylpropane-1,3-dione respectively) and 5 mL of 85%
H3PO4 in H2O were reﬂuxed for 24 h, then the reaction mixture was
cooled at room temperature and treated as reported by Grodzicki.
2.5. Synthesis of dbtp adducts
Diorganotin(IV)dichloride-dbtp adducts were prepared reacting the
organometallic compound (1 mmol) with dbtp (1 or 2 mmol) in diethyl
ether (20 mL). After reducing the volume of the clear reaction mixture
in air, 1:1 or 1:2 solid adducts were obtained depending on the reaction
ratio. n-BuSnCl3 gave the 1:2 adduct independently of the reaction ratio:
a bulky precipitate is formed immediately after mixing the reagents.
The complexes were recrystallized from diethyl ether. Single crystals of
Et2SnCl2(dbtp)2 suitable for X-ray diffraction studies were obtained by
slow evaporation of diethyl ether solution at room temperature.
2.5.1. Me2SnCl2(dbtp) (1) and Me2SnCl2(dbtp)2 (2)
C15H26Cl2N4Sn (452.02) (1), m.p.152–154 °C; Anal. Calc.: C, 39.86;
H, 5.80; N, 12.39; Cl, 15.69; Sn, 26.26. Found: C, 39.81; H, 6.02; N,
12.31; Cl, 15.06; Sn, 25.52%. Selected IR data (CsI, cm−1):1615 s
(strong) (νtp), 1532 s (νpy), 576 m (medium) νas(Sn–C); 520w
(weak) νs(Sn–C); 322 s νas(Sn–Cl); 273 s νs(Sn–Cl). 1H NMR
(CDCl3): δ (ppm)=8.58 (s (singlet), 1H, H-2), 7.11 (s, 1H, H-6),
1.64 (s, 9H, H-5), 1.45 (s, 9H, H-7), 1.30 (s, 6H, Sn–CH3), |2J(119Sn,
H)|=78.8 Hz ∠C–Sn–C=127.7°, |2J(117Sn,H)|=75.6 Hz ∠C–Sn–
C=125.6°. 13C NMR (CDCl3): δ (ppm)=152.9 (C-2), 154.3 (C-3a),
177.4 (C-5), 104.6 (C-6), 158.6 (C-7), 36.7, 39.2, 27.2, 29.8 (C
(CH3)3); 10.8 (Sn–CH3). 119Sn Mössbauer data: δ=1.37, ΔE=3.46,
Γ±=0.83 mm s−1, ∠C–Sn–C=132°. C28H46Cl2N8Sn (684.35) (2);
m.p. 142–144 °C. Anal. Calc.: C, 49.14; H, 6.78; N, 16.37; Cl, 10.36;
Sn, 17.35. Found: C, 49.28; H, 6.75; N, 16.85; Cl, 10.73; Sn, 17.33%. Se-
lected IR data (CsI, cm−1):1615 s (νtp), 1535 s (νpy), 579 m νas(Sn–
C); 261 s νas(Sn–Cl). 1H NMR (CDCl3): δ (ppm)=8.52 (s, 1H, H-2),
7.07 (s, 1H, H-6), 1.63 (s, 9H, C(CH3)3), 1.45 (s, 9H, C(CH3)3), 1.31
(s, 6H, Sn–CH3), |2J(119Sn,H)|=80.4 Hz ∠C–Sn–C=131.4°, |2J(117Sn,
H)|=76.96 Hz ∠C–Sn–C=127.2°. 13C NMR (CDCl3): δ (ppm)=
153.4 (C-2), 155.7 (C-3a), 176.8 (C-5), 104.2 (C-6), 158.3 (C-7);
36.6, 39.1, 27.2, 29.8 (C(CH3)3); 12.5 (Sn–CH3). 119Sn Mössbauer
data: δ=1.37, ΔE=3.90, Γ±=0.79 mm s−1, ∠C–Sn–C=158°.
2.5.2. Et2SnCl2(dbtp) (3) and Et2SnCl2(dbtp)2 (4)
C17H30Cl2N4Sn (480.07) (3); m.p. 83–85 °C. Anal. Calc.: C, 42.53;
H, 6.30; N, 11.67; Cl, 14.77; Sn, 24.73. Found: C, 42.94; H, 6.36; N,12.01; Cl, 15.08; Sn, 25.15%. Selected IR data (CsI, cm−1):1615 s
(νtp), 1531 s (νpy);540 m νas(Sn–C); 499 m νs(Sn–C); 314 s νas(Sn–
Cl); 269 s νs(Sn–Cl). 1H NMR (CDCl3): δ (ppm)=8.56 (s, 1H, H-2),
7.09 (s, 1H, H-6), 1.63 (s, 9H, C(CH3)3), 1.45 (s, 9H, C(CH3)3), 1.84
(q (quartet), 4H, Sn–C2H5), |2J(119Sn,H)|=57.8 Hz ∠C–Sn–
C=110.9°, |2J(117Sn,H)|=55.4 Hz ∠C–Sn–C=109.7°, 1.41(t (triplet),
6H, Sn–C2H5), |3J(119Sn,H)|=144.1 Hz, |3J(117Sn,H)|=137.6 Hz. 13C
NMR (CDCl3): δ (ppm)=153.6 (C-2), 154.7 (C-3a), 177.0 (C-5),
104.4 (C-6), 158.4 (C-7); 36.6, 42.8, 27.2, 29.8 (C(CH3)3); 21.8 (Sn–
C2H5), 9.8 (Sn–C2H5, |2J(119Sn,C)|=44.2 Hz).119Sn Mössbauer data:
δ=1.49, ΔE=3.37, Γ±=0.78 mm s−1, ∠C–Sn–C=130°. C30H50Cl2-
N8Sn (712.37) (4); m.p. 91–93 °C. Anal. Calc.: C, 50.58; H, 7.07; N,
15.73; Cl, 9.95; Sn, 16.66. Found: C, 50.61; H, 7.03; N, 15.57; Cl,
10.17; Sn 16.84%. Selected IR data (CsI, cm−1):1613 s (νtp), 1530 s
(νpy); 536 m νas(Sn–C); 495 νs(Sn–C); 260 s,br (broad) νas(Sn–Cl).
1H NMR (CDCl3): δ (ppm)=8.49 (s, 1H, H-2), 7.04 (s, 1H, H-6), 1.63
(s, 9H, C(CH3)3), 1.45 (s, 9H, C(CH3)3), 1.83 (q, 4H, Sn–C2H5), |2J
(119Sn,H)|=58.6 Hz ∠C–Sn–C=111.3°, |2J(117Sn,H)|=56.2 Hz ∠C–
Sn–C=110.1°, 1.42(t, 6H, Sn–C2H5), |3J(119Sn,H)|=144.6 Hz, |3J
(117Sn,H) |=138.4 Hz. 13C NMR (CDCl3): δ (ppm)=153.6 (C-2),
154.9 (C-3a), 176.7 (C-5), 104.2 (C-6), 158.2 (C-7); 36.5, 39.0, 27.1, 29.7
(C(CH3)3); 23.9 (Sn–C2H5), 9.9 (Sn–C2H5, |2J(119Sn,C)|=48.2 Hz).119Sn
Mössbauer data: δ=1.57, ΔE=3.87, Γ±=0.76 mm s−1, ∠C–Sn–
C=157°.2.5.3. Bu2SnCl2(dbtp)2 (5)
C34H58Cl2N8Sn (768.51) (5); m.p. 61–63 °C. Anal. Calc.: C, 53.14;
H, 7.61; N, 14.58; Cl, 9.23; Sn, 15.45. Found: C, 53.51; H, 7.06; N,
14.94; Cl, 9.24; Sn 15.42%. Selected IR data (CsI, cm−1):1615 s (νtp),
1535 s (νpy); 592 m νas(Sn–C); 517w νas(Sn–Cl); 268 m,br νs(Sn–
Cl). 1H NMR (CDCl3): δ (ppm)=8.50 (s, 1H, H-2), 7.05 (s, 1H, H-6),
1.62 (s, 9H, C(CH3)3), 1.44 (s, 9H, C(CH3)3), 1.86–1.78 m (multiplet),
1.37 m, 0.87 t (18H, Sn-nC4H9). 13C NMR (CDCl3): δ (ppm)=153.9
(C-2), 155.3 (C-3a), 176.5 (C-5), 104.0 (C-6), 158.1 (C-7); 36.5, 39.1,
27.2, 29.8 (C(CH3)3); 26.4, 30.3, 27.4, 13.7 (Sn–nC4H9). 119Sn Möss-
bauer data: δ=1.55, ΔE=3.89, Γ±=0.75 mm s−1, ∠C–Sn–C=158°.2.5.4. Ph2SnCl2(dbtp) (6)
C25H30Cl2N4Sn (576.16) (6); m.p. 107–109 °C. Anal. Calc.: C,
52.12; H, 5.25; N, 9.72; Cl, 12.31; Sn, 20.60. Found: C, 52.02; H,
5.22; N, 9.79; Cl, 12.32; Sn, 20.51%. Selected IR data (CsI,
cm−1):1614 s (νtp), 1532 s (νpy); 282 m νas(Sn–C); 223 m νas(Sn–
Cl). 1H NMR (CDCl3): δ (ppm)=8.53 (s, 1H, H-2), 7.01 (s, 1H, H-6),
1.61 (s, 9H, C(CH3)3), 1.35 (s, 9H, C(CH3)3), 7.76–7.73 (m, 4H, Sn–
C6H5 ortho, |3J(119Sn,C)|=91.7 Hz), 7.48 (m, 6H, Sn–C6H5 meta+
para). 13C NMR (CDCl3): δ (ppm)=153.8 (C-2), 155.1 (C-3a), 176.5
(C-5), 104.0 (C-6), 157.9 (C-7); 36.5, 39.0, 27.2, 29.7 (C(CH3)3);
139.5 (Sn–C6H5 ipso), 135.2 (Sn–C6H5 ortho, |2J(119Sn,C)|=64.2 Hz,
2J(117Sn,C)=62.1 Hz, 129.6 (Sn–C6H5 meta, |3J(119Sn,C)|=90.2 Hz,
|3J(117Sn,C)|=86.3 Hz), 131.4 (Sn–C6H5 para, |4J(119Sn,C)|=
19.8 Hz, |4J(117Sn,C)|=17.8 Hz). 119Sn Mössbauer data: δ=1.23
ΔE=2.77, Γ±=0.85 mm s−1, ∠C–Sn–C=125°.2.5.5. BuSnCl3(dbtp)2 (7)
C30H49Cl3N8Sn (746.85) (7); m.p. 152–154 °C. Anal. Calc.: C, 48.25;
H, 6.61; N, 15.00; Cl, 14.24; Sn, 15.90. Found: C, 48.32; H, 6.89; N,
14.93; Cl, 14.25; Sn, 16.37%. Selected IR data (CsI, cm−1):1615 s (νtp),
1535 s (νpy); 602w νas(Sn–C); 311 m, 292 m, 255w ν(Sn–Cl). 1H NMR
(CDCl3): δ (ppm)=8.72 (s, 1H, H-2), 7.1 (s, 1H, H-6), 1.63 (s, 9H, C
(CH3)3), 1.43 (s, 9H, C(CH3)3), 2.56–1.90 (m, 4H, Sn–nC4H9), 1.48 (m,
8H, Sn–nC4H9), 0.90 (t, 6H, Sn–nC4H9). 13C NMR (CDCl3): δ (ppm)=
152.9 (C-2), 154.0 (C-3a), 177.6 (C-5), 104.8 (C-6), 158.6 (C-7); 36.7,
39.3, 27.4, 29.8 (C(CH3)3); 25.8, 29.9, 27.6, 13.8 (Sn–nC4H9). 119Sn
Mössbauer data: δ=1.00, ΔE=2.06, Γ±=0.79 mm s−1.
Fig. 2. Crystal structure of Et2SnCl2(dbtp)2 (4) showing the crystallographic numbering
(ORTEP at 30% probability).
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Me2SnCl2(dptp)2 (8) and n-BuSnCl3(dptp)2 (12)were obtained by
reaction of the organotin(IV) chloride and dptp in ethanol: the mix-
ture was reﬂuxed for 2 h giving a clear solution; on cooling to room
temperature crystalline products were obtained. Under the same con-
ditions Ph2SnCl2 gave the adduct Ph2SnCl2(EtOH)2(dptp)2 (11). The
compounds (8), (11) and (12) were recrystallized from ethanol. A
further treatment of the compounds with diethyl ether at room tem-
perature didn't give any modiﬁcation in their spectroscopic proper-
ties. By a similar procedure, compounds Et2SnCl2(dptp) (9) and
Bu2SnCl2(dptp) (10) were obtained from diethyl ether solutions.
2.6.1. Me2SnCl2(dptp)2 (8)
C36H30Cl2N8Sn (764.31) (8); m.p. 179–181 °C.Anal. Calc.: C, 56.57;
H, 3.96; N, 14.66; Cl, 9.28; Sn, 15.53. Found: C, 56.86; H, 4.01; N,
14.66; Cl, 9.08; Sn, 15.50%. Selected IR data (CsI, cm−1):1612 s (νtp),
1546 s (νpy); 580 m νas(Sn–C); 248w νas(Sn–Cl). 1H NMR (CDCl3): δ
(ppm)=8.60 (s, 1H, H-2), 7.72 (s, 1H, H-6), 7.66–7.57 (m, 5H,
C6H5), 8.27–8.12 (m, 5H, C6H5), 1.34 (s, 6H, Sn–CH3), 2J(119Sn,H):
77.4 Hz ∠C–Sn–C=127.7°, 2J(117Sn,H): 74.0 Hz ∠C–Sn–C=122.9°.
13C NMR (CDCl3): δ (ppm)=156.4 (C-2), 155.8 (C-3a), 162.4 (C-5),
107.1 (C-6), 148.6 (C-7), 128.0,129.6 (Cortho), 129.4, 129.3 (Cmeta),
131.9, 132.3 (Cpara), 130.0, 136.3 (Cipso), 10.4 (Sn–CH3). 119Sn Möss-
bauer data: δ=1.40, ΔE=4.17, Γ±=0.75 mm s−1, ∠C–Sn–C=180°.
2.6.2. Et2SnCl2(dptp) (9)
C21H22Cl2N4Sn (520.0) (9); m.p. 153–155 °C. Anal. Calc.: C,
48.50; H, 4.26; N, 10.77; Cl, 13.63; Sn, 22.83. Found: C, 48.79; H,
4.25; N, 11.02; Cl, 13.32; Sn, 23.20%. Selected IR data (CsI,
cm−1):1615 s (νtp), 1543 s (νpy); 540 m νas(Sn–C); 499 m νs
(Sn–C); 314 s νas(Sn–Cl); 269 m νs(Sn–Cl). 1H NMR (CDCl3): δ
(ppm)=8.61(s, 1H, H-2), 7.72 (s, 1H, H-6), 7.67–7.58 (m, 5H,
C6H5), 8.28–8.13 (m, 5H, C6H5), 1.84(q, 4H, Sn–C2H5), 2J(119Sn,
H): 52.8 Hz, 2J(117Sn,H): 50.8 Hz, 1.45(t, 6H, Sn–C2H5), 3J(119Sn,
H): 139.0 Hz, 3J(117Sn,H): 132.9 Hz. 13C NMR (CDCl3): δ (ppm)=
155.9 (C-2), 155.7 (C-3a), 162.4 (C-5), 107.2 (C-6), 148.7 (C-7),
128.0,129.6 (Cortho), 129.4, 129.3 (Cmeta), 131.9, 132.3 (Cpara),
130.0, 136.3 (Cipso), 20.7(Sn–C2H5), 9.7 (Sn–C2H5). 119Sn Möss-
bauer data: δ=1.54, ΔE=3.54, Γ±=0.80 mm s−1, ∠C–Sn–
C=134°.
2.6.3. Bu2SnCl2(dptp) (10)
C25H30Cl2N4Sn (576.16) (10); m.p. 76–78 °C. Anal. Calc.: C, 52.12;
H, 5.25; N, 9.72; Cl, 12.31; Sn, 20.60. Found: C, 52.39; H, 5.38; N,
10.03; Cl, 12.37; Sn 20.32%. Selected IR data (CsI, cm−1):1610 s
(νtp), 1542 s (νpy); 687 m νas(Sn–C); 334 m νas(Sn–Cl); 281 m νs
(Sn–Cl). 1H NMR (CDCl3): δ (ppm)=8.62 (s, 1H, H-2), 7.73(s, 1H,
H-6), 7.67–7.56 (m, 5H, C6H5), 8.27–8.13 (m, 5H, C6H5), 1.91–
1.77 m, 1.42dd, 0.93 t (18H, Sn–nC4H9). 13C NMR (CDCl3): δ
(ppm)=155.9 (C-2), 155.8 (C-3a), 162.3 (C-5), 107.1 (C-6), 148.6
(C-7); 128.0,129.6 (Cortho), 129.4, 129.2 (Cmeta), 131.9, 132.3 (Cpara),
130.0, 136.3 (Cipso), 26.5, 28.2, 27.3, 13.7 (Sn–nC4H9). 119Sn Mössbauer
data: δ=1.49, ΔE=3.35, Γ±=0.83 mm s−1, ∠C–Sn–C=129°.
2.6.4. Ph2SnCl2(EtOH)2(dptp)2 (11)
C50H46Cl2N8O2Sn (980.54) (11); m.p. 133–135 °C. Anal. Calc.: C,
61.24; H, 4.73; N, 11.43; Cl, 7.23; Sn, 12.11. Found: C, 60.97; H, 4.27;
N, 11.30; Cl, 7.66; Sn 12.41%. Selected IR data (CsI, cm−1):1610 s
(νtp), 1539 s (νpy); 290 m νas(Sn–C); 249 m νas(Sn–Cl). 1H NMR
(CDCl3): δ (ppm)=8.54 (s, 1H, H-2), 7.66 (s, 1H, H-6), 7.48–7.46,
7.64–7.62 (m, 5H, C6H5), 8.20–8.09 (m, 5H, C6H5), 7.79–7.76 (m, 4H,
Sn–C6H5 meta, 7.55–7.51 (m, 6H, Sn–C6H5 ortho+para); 3.73 (q, 4H,
EtOH), 1.25 (t, 6H, EtOH).13C NMR (CDCl3): δ (ppm)=156.1 (C-2),
156.0 (C-3a), 162.0 (C-5), 106.9 (C-6), 148.4 (C-7), 128.0,129.5 (Cortho),
129.3, 129.2 (Cmeta), 131.7, 132.1 (Cpara), 130.1, 136.3 (Cipso), 139.0(Sn–C6H5 ipso), 135.2 (Sn–C6H5 ortho), 129.6 (Sn–C6H5 meta),
131.7 (Sn–C6H5 para); 58.6 (CH2, EtOH), 18.6 (CH3, EtOH). 119Sn
Mössbauer data: δ=1.26, ΔE=3.82, Γ±=0.83 mm s−1, ∠C–Sn–
C=180°.
2.6.5. BuSnCl3(dptp)2 (12)
C38H33Cl3N8Sn (826.81) (12); m.p. 125–127 °C. Anal. calc.: C,
55.20; H, 4.02; N, 13.55; Cl, 12.86; Sn, 14.36. Found: C, 55.05; H,
4.14; N, 13.27; Cl, 12.61; Sn 14.90%. Selected IR data (CsI,
cm−1):1615 s (νtp), 1541 s (νpy); 602 m ν(Sn–C); 326w, 296 m
257w,br ν(Sn–Cl). 1H NMR (CDCl3): δ (ppm)=8.71 (s, 1H, H-2),
7.76(s, 1H, H-6), 7.69–7.56 (m, 5H, C6H5), 8.28–8.09 (m, 5H, C6H5),
2.59(m, 4H, Sn–nC4H9), 2.02–1.92 (m, 4H, Sn–nC4H9),1.50 (m, 4H,
Sn–nC4H9), 0.92 (t, 6H, Sn–nC4H9). 13C NMR (CDCl3): the spectrum
not be recorded because of its poor solubility. 119Sn Mössbauer
data: δ=0.98, ΔE=2.11, Γ±=0.83 mm s−1.
3. Results and discussion
3.1. Solid state studies
3.1.1. Crystal structure of Et2SnCl2(dbtp)2 (4)
The crystal and molecular structure of Et2SnCl2(dbtp)2 (4) is
shown in Fig. 2 together with the crystallographic labeling. Relevant
bond distances and angles are reported in Table 2. The molecule is
symmetric and the Sn atom sits on a crystallographic glide plane, so
that only half a molecule constitutes the asymmetric unit. The Sn
atom is hexacoordinate, with the triazolopyrimidine ligand being di-
rectly coordinated to the metal and acting as a monodentate ligand
through a single nitrogen atom, as often found in compounds provid-
ed with a direct metal-triazolopyrimidine bond.
In a series of metal coordinated triazolopyrimidine compounds in-
vestigated through X-ray diffraction, the most frequent geometry
found in the structural analysis is octahedral with two (or four) tria-
zolo-[1,5-a]pyrimidine ligands monodentately coordinated via the ni-
trogen atom in position 3, with strong metal-to-N interaction [1]. On
the other hand, compound 4 contains two weakly bound triazolo-
pyrimidine ligands and exhibits a highly distorted octahedral geometry
of the coordination around the Sn atom, resulting in a C–Sn–C angle of
157.6(2)°. Thus, the overall geometry about the Sn atom is best de-
scribed as a skew-trapezoidal bipyramid with the tin-bonded carbon
atoms of the ethyl groups being bound in pseudo-axial positions over
Table 2
Selected bond lengths (Å) and angles (°).
Compound 4a Compound 11b
Sn–C(1) 2.114(4) Sn–C(1) 2.1441(13)
Sn–N(3) 2.603(2) Sn–O(1) 2.2705(19)
Sn–Cl(1) 2.4640(8) Sn–Cl(1) 2.5383(7)
C(1)–Sn–C(1) 157.56(19) C(1)–Sn–C(1) 180.0
C(1)–Sn–N(3) 82.91(10) C(1)–Sn–O(1) 90.58(8)
C(1)–Sn–N(3) 81.38(11) C(1)–Sn–O(1) 89.42(8)
N(3)–Sn–N(3) 90.80(10) O(1)–Sn–O(1) 180.0
C(1)–Sn–Cl(1) 95.08(9) C(1)–Sn–Cl(1) 89.36(5)
C(1)–Sn–Cl(1) 99.64(10) C(1)–Sn–Cl(1) 90.64(5)
Cl(1)–Sn–N(3) 85.75(5) O(1)–Sn–Cl(1) 91.73(6)
Cl(1)–Sn–N(3) 176.24(5) O(1)–Sn–Cl(1) 88.27(6)
Cl(1)–Sn–Cl(1) 97.73(5) C(1)–Sn–Cl(1) 90.64(5)
C(1)–Sn–Cl(1) 89.36(5)
O(1)–Sn–Cl(1) 88.27(6)
O(1)–Sn–Cl(1) 91.73(6)
Cl(1)–Sn–Cl(1) 180.0
a Symmetry transformations used to generate equivalent atoms: I 1/2-x, y, -z.
b Symmetry transformations used to generate equivalent atoms: I 1-x, 1-y, -z.
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(2)Å, respectively]. Although this latter Sn\N bond distance is quite
long, it is considerably less than the sum of their van der Waals radii
(3.75 Å), therefore it should be considered as a bonding interaction.
The angle at the tin atom formed between N(1) and Cl(1), 176.2(2)°,
is indicative of the trans positions of the ligands, while the cis ligands,Fig. 3. Packing of Et2SnCl2(dbtp)2 (4) viewed along the c axis.Cl–Sn–C(1) angle is signiﬁcantly widened to 99.6(1)°, Cl–Sn–Cl is also
widened to 97.7(1)° while N(1)–Sn–C(1) is 82.9(1)°.
Supramolecular organization: The reason for the highly dis-
torted octahedral geometry around the Sn atom can be explained
taking into account the supramolecular organization of the com-
pound. Actually, non-conventional H-bonding interactions be-
tween hydrogen atoms belonging to \CH methyl groups of one
molecule and Cl atoms of a second one (Cl···H–C distance 2.91
(1) Å, D···A distance 3.857(3)Å, Cl···H–C angle 171.1(1)°) create
an inﬁnite polymeric arrangements of molecules forming rows of
columns elongated along the c axis, shown in Fig. 3 (a) in wires
(H-bonds in dotted lines) and in spaceﬁll representation, Fig. 3 (b).More-
over, a further stabilization is given by some intramolecular C–H···N in-
teractions and aπ-stacking aromatic intramolecular interaction occurring
between the two symmetry-related six-membered pyrimidine rings
which lay 4.7 Å apart from each other. The two rings may be deﬁned as
inclined, making an angle of 40° between their mean planes, according
to the geometries of aromatic interactions deﬁned by Aravinda et al. for
peptide scaffolds [30].
3.1.2. Crystal structure of Ph2SnCl2(EtOH)2(dptp)2 (11)
In Ph2SnCl2(EtOH)2(dptp)2 (11), whose structure is shown in
Fig. 4, the tin atom sits on a crystallographic inversion center and,
also in this case, only half a molecule constitutes the crystallographic
independent unit. The ligands at Sn(IV) are two phenyl rings and two
chlorine atoms. The octahedral geometry is completed by two ethanol
molecules which coordinate the Sn atom through their oxygen atoms,
which coordinate further two dptpmolecules, not directly connected
to the metal centre but H-bonded in a quite strong interaction [O∙∙∙N
distance 2.698(3) , O–H∙∙∙N angle 175(1)°] through the triazole N
(3) atom. In addition, the dptp molecules are more loosely held via
a second H-bond interaction trough the pyrimidine N(4) and one H
atom belonging to the terminal methyl group, C(25). According to lit-
erature data [1], a few compounds have been described in whichFig. 4. Molecular structure of Ph2SnCl2(EtOH)2(dptp)2 (11) showing the crystallo-
graphic labeling of the independent part of the molecule (ORTEP at 50% probability).
Fig. 5. Packing of Ph2SnCl2(EtOH)2(dptp)2 (11), showing the π stacking of the triazolo pirimidine pairs and the aromatic–aromatic interactions (chlorine and ethanol ligands and
hydrogen atoms have been omitted for clarity).
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imidine derivative. When the dmtp is protonated at N(3) behaving as
a counterion of a complex such as [SnCl6]2− [31] cations associate in
hydrogen bonded N(3)–H∙∙∙N(4) couples, conﬁrming the fact that N
(3) and N(4) positions are the most common sites for bidentate coor-
dination. In 11, the Sn–Cl distance, 2.538(1) Å, trans to the same
weak-ﬁeld chlorine ligand, is considerably longer than the one found in
4, Sn–Cl(1) 2.4640(8) Å, trans to the N(3) of the triazolo moiety. Also in
Ph2SnCl2L∙EtOH [32] (where L=3-methyl-2-hydroxy-2-cyclopenten-1-
one), the metal-to-chlorine interaction is 2.313(1) Å, having an O-
bound ethanol molecule as a transoid ligand [Cl–Sn–O 166.1(1)°], due
to the increased π-acceptor properties of the ligand. Consistently, in 11,
the Sn–O (ethanol) interaction, 2.271(1) Å, trans to itself, appears again
considerably longer than the value, 2.118(3) Å, found in the previously
mentioned in Ph2SnCl2L∙EtOH complex [32]. The dihedral angle between
the strictly planar triazolopyrimidinemoiety [maxdeviation fromplanar-
ity for C(9), 0.0270 Å] and the plane containing Sn, Cl(1) and O(1) is
50.08°, while the angle between the tpmoiety and the Sn-bound phenyl
ring [C(1) to C(6)] is 68.36°. Strong π-stacking “antiparallel” interactions
between pairs of triazolopyrimidinemoieties, related by the Ci symmetry
operator, occur with a centroid–centroid distance of 3.7 Å. In addition to
these, a close network of edge-to-face and π-stacking interactions in-
volving all the aromatic rings present in the molecule [CH-centroid
and centroid–centroid distances in the range of 4.2–4.4 Å] contributes
to a further stabilization of the structure (Fig. 5).
3.1.3. IR spectra and Mössbauer data
The IR spectra of the complexes have been examined in compari-
son with the spectra of the free ligands [33]. The two most character-
istic bands in the IR spectra of dbtp and dptp, assigned to an overall
triazolopyrimidine and pyrimidine ring mode vibrations, νtp (1615
and 1612 cm−1) and νpy (1530 and 1543 cm−1), are generally
moved to higher frequencies in transition metal complexes [34,35].
In the organotin(IV) derivatives under investigation, not signiﬁcant
shift on coordination is found, presumably due to the extensive hy-
drogen bonds network in both ligand [36] and investigated com-
pounds. The only differences in the spectra are due to ν(Sn–C) and
ν(Sn–Cl) stretching vibrations in the low-frequency region [37,38].
The values of the Mössbauer quadrupole splittings parameters give
very useful information on the solid-state structure of the diorgano-
tin(IV) complexes as they can be related to the geometry of the dior-
ganotin(IV) moiety: the C\Sn\C bond angle in such compounds can
be simply estimated through “point-charge” calculations assuming
that the quadrupole splitting is set up just by the R2Sn unit, the con-
tribution to the electric ﬁeld gradient on the tin nucleus being domi-
nated by the highly covalent Sn\C bonds [39]. Hence, idealizedoctahedral and cis-R2 trigonal bipyramidal structures for R2SnCl2L2
and R2SnCl2L complexes, respectively, are proposed (L=dbtp or
dptp). Using the partial quadrupole splitting (p.q.s.) values [40]
−1.03 and −1.13 mm s−1 [41] for octahedral and equatorial trigonal
bipyramidal alkyl groups respectively, and −0,95 and −0.98 mm s−1
for the corresponding phenyl groups, the C\Sn\C bond angles were
estimated as reported under the analitical data. As far as the 1:1 com-
plexes are concerned, compounds 1, 3, 6, 9, and 10, the estimated
C\Sn\C bond angles are in the range 125–134° according to a dis-
torted cis-R2 tbp structure (Fig. 6a). Among the 1:2 complexes, 8 and
11 are characterized by an essentially linear C–Sn–C fragment
(Fig. 6b), according to the presence of only one ν(Sn–C) band in the in-
frared spectrum of 8, and, most of all, to the X-ray all-trans structure of
11. The dbtp derivatives 2, 4 and 5 are characterized by quite similar
Mössbauer spectra which suggests distorted octahedral structures
(Fig. 6c), with C\Sn\C bond angles lower than 180°. The estimated
angle for Et2SnCl2(dbtp)2 (4) is virtually identical to that determined
byX-ray diffraction, showing that for this class of compounds themeth-
od can be considered particularly efﬁcient. As far as the monoorganotin
(IV) derivatives 7 and 12 are concerned, we may only observe that the
quadrupole splitting values are consistent with octahedral structures.
3.2. Solution state studies
3.2.1. 1H and 13C NMR spectra
Structural informations for the complexes in solution have been
acquired by 1H, 13C and 1H–1H COSY (correlation spectroscopy) spec-
tra. 1H and 13C NMR relevant resonances for the free ligands and the
complexes performed in CDCl3 (see Experimental section). The 1H
resonances of the dbtp ligand are assigned according to Szlyk [42];
assignments of dptp resonances in CDCl3 (8.55 ppm for H(2),
7.68 ppm for H(6), 7.65–7.55 and 8.29–8.12 ppm for C6H5 group)
and for 13C NMR spectra are in agreement with those reported by
Grodzicki [29] in DMSO-d6. The 1H NMR spectra for the novel dbtp
complexes present two characteristic singlet signals of H(2) and H
(6) in the range 7.01–8.72 ppm, and similarly resonances for dptp
are in the range 7.66–8.71 ppm. The spectra are slightly modiﬁed,
with the same multiplicity of signals, with respect to the ligands.
The coordination of triazolopyrimidine derivatives by organotin(IV)
results in the downﬁeld shift of H(2) and H(6) resonances. Coordina-
tion via N(3) slightly affects the 13C spectrum of the ligands: the car-
bons adjacent to N(3) coordination site, i.e. C(2) and C(3a) are shifted
upﬁeld whereas those of C(5), C(6) and C(7) are moved in the oppo-
site direction. Coordination via N(3) of these two ligands is in agree-
ment with similar results presented for platinum(II) and palladium
(II) chloride complexes [35]. As for the organometallic moieties, 1H
Fig. 6. Proposed structures for R2SnL and R2SnL2 complexes: (a) R=Me, Et, Ph; L=dbtp; R=Et, n-Bu; L=dptp. (b) L=Me, Ph; L=dptp. (c) R=Me, Et, n-Bu; L=dbtp.
Fig. 7. 1H–1H COSY spectrum for Ph2SnCl2(EtOH)2(dptp)2 .
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plexes, present a single resonance at 1.30 and 1.31 ppm, respectively.
Lockhart and Manders' relationship [43] between C\Sn\C bond an-
gles and |2J| can be applied. For Me2SnCl2(dbtp) (1), |2J(119Sn, 1H)|
being 78.8 Hz, the calculated C\Sn\C bond angle is 129.3° while in
Me2SnCl2(dbtp)2 (2), |2J(119Sn, 1H)| being 80.4 Hz, a C\Sn\C bond
angle of 131.4° was obtained. There are no signiﬁcant differences be-
tween the Me2SnCl2(dbtp) and Me2SnCl2(dbtp)2 complexes, which
suggests that even in a non-coordinating solvent solution, a ligand
unit has been displaced. A similar trend has been observed following
the comparison between Et2SnCl2(dbtp) and Et2SnCl2(dbtp)2 com-
plexes, |2J(119Sn, 1H)| being 57.8 Hz, the calculated C\Sn\C bond
angle is 110.9° and |2J(119Sn, 1H)| being 58.6 Hz, the calculated
C\Sn\C bond angle is 111.3°, respectively. For the complex Me2-
SnCl2(dptp)2 (8), |2J(119Sn, 1H)| being 77.4 Hz, the calculated
C\Sn\C bond angle is 127.7°, while for Et2SnCl2(dptp) (9), |2J
(119Sn, 1H)| being 52.8 Hz, the calculated C\Sn\C bond angle is
108.6°. The aromatic proton resonances of Ph2SnCl2(dbtp) (6) are
found in two groups at 7.76–7.73 ppm (corresponding to four pro-
tons) which are observed at lower ﬁelds due to ortho hydrogens of
the phenyl groups attached to tin, and 7.48 ppm (corresponding to
six protons) as multiplets due to meta and para hydrogens [44]. For
Ph2SnCl2(EtOH)2(dptp)2 (11) whose resonance assignments are
reported under Experimental, 1H–1H COSY spectrum is presented in
Fig. 7. In all NMR spectra sharpness of resonances gives an indication
thatﬂuxionality is absent, even for coordinated ethanolmolecules in 11.
3.3. Antimicrobial activity
The compoundswere screened for their in vitro antibacterial activity
on a group of reference staphylococcal strains susceptible or resistant to
methicillin and against two reference Gram-negative pathogens. The
antibacterial activity of the substances, expressed as MIC, is reported
in Table 3. The free ligands dbtp and dptp resulted inactive at the max-
imum tested concentration of 100 μg mL−1, whereas organotin(IV)
complexes show a better antibacterial activity against Gram-positive
strains. Ph2SnCl2(EtOH)2(dptp)2 (11) and n-Bu2SnCl2(dbtp)2 (5)
showed good antibacterial activity with a MIC value of 5 and
10 μg mL−1 respectively against S. aureus ATCC29213 and the com-
pound n-Bu2SnCl2(dbtp)2 (5) showed an interesting activity, (MIC
value of 20 μg mL−1) against the methicillin resistant strain S. aureus
ATCC43866 too. Ph2SnCl2(dbtp) (6), Ph2SnCl2(EtOH)2(dptp)2 (11), n-
Bu2SnCl2(dptp) (10) and n-BuSnCl3(dbtp)2 (7) resulted active against
methicillin resistant S. epidermidis RP62A, but unfortunately showed a
weak or no activity against the other strains. However, none of the com-
pounds resulted active against all the tested staphylococcal strains. The
signiﬁcative antibacterial properties of the above mentioned organotin
(IV) complexes, among these,most active being Ph2SnCl2 and n-Bu2SnCl2
derivatives, were encouraging. Inhibitory activity increases in theorder Me~Etbn-BubPh and is attributed to lipophilicity, following
the same trend, which facilitates microorganism membrane cross-
ing, in agreement with the knowledge that the toxicity of the orga-
notins is related to their hydrophobicity [45,46]. A qualitative
structure-activity relationship can tentatively be advanced, where co-
ordination environment of the tin atom is crucial: six-coordinated tin
complex, Ph2SnCl2(EtOH)2(dptp)2 (11), displayed better results than
the ﬁve-coordinated Ph2SnCl2(dbtp) one (6) against S. aureus ATCC
29213. The extensive hydrogen bonds network which is present in the
former [36] is indicative of the potential mode action of this compound
which could be described in terms of hydrogen bonding with the active
centers of the cell constituents, resulting in an interference,with thenor-
mal cell processes. All the complexes and the parent compounds showed
poor activity against Gram-negative reference strains, with the excep-
tion of Et2SnCl2, which showed aMIC value of 40 μg mL−1 against P. aer-
uginosaATCC9027 and E. coliATCC25922. The complexes Et2SnCl2(dbtp)
(3), Et2SnCl2(dbtp)2 (4) and Et2SnCl2(dptp) (9), exhibited antibacterial
properties less potent than the parent organotin(IV) compounds. As an
overall result, the complexes were more toxic towards Gram-positive
than Gram-negative strains; the reason laying in the different structures
of cell walls, which in Gram-negative cells are more complex than those
in the Gram-positive ones [12].
Table 3
Anti-staphylococcal activity in vitro, MIC values in μg mL−1.
Compound S. aureus
ATCC 29213
S. aureus
ATCC 25923
S. aureus
ATCC 43866
S. epidermidis
RP62A
Me2SnCl2 N40 a N40 N40
Me2SnCl2⋅dbtp (1) N40 N40 N40 N40
Me2SnCl2(dbtp)2 (2) N40 N40 N40 N40
Me2SnCl2(dptp)2 (8) N40 N40 N40 N40
Et2SnCl2 20 a 20 20
Et2SnCl2(dbtp) (3) N40 N40 N40 N40
Et2SnCl2(dbtp)2 (4) N40 N40 N40 N40
Et2SnCl2(dptp) (9) N40 N40 N40 N40
n-Bu2SnCl2 40 a N40 N40
n-Bu2SnCl2(dbtp)2 (5) 10 N40 20 N40
n-Bu2SnCl2(dptp) (10) 40 N40 N40 10
Ph2SnCl2 20 a N40 1.2
Ph2SnCl2(dbtp) (6) 20 N40 N40 5
Ph2SnCl2(EtOH)2
(dptp)2 (11)
5 N10 N10 5
n-BuSnCl3 N40 N40 N40 1.2
n-BuSnCl3(dbtp)2 (7) N20 N20 N20 20
n-BuSnCl3(dptp)2 (12) N40 N40 N40 N40
dbtp N100 N100 N100 N100
dptp N100 N100 N100 N100
Amikacin 1.2 a 1.2 1.2
a MIC value published on reference [8].
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A considerable series (twelve novel compounds are reported) of 5,7-
ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine (dbtp) and 5,7-diphenyl-
1,2,4-triazolo[1,5-a]pyrimidine (dptp) were synthesized and investi-
gated by FT-IR and 119Sn Mössbauer in the solid state and by 1H and
13C NMR spectroscopy, in solution. The X-ray crystal and molecular
structures of Et2SnCl2(dbtp)2 (4) and Ph2SnCl2(EtOH)2(dptp)2 (11)
were described. The main result of the structural investigations of com-
plexes 4 and 1 lies in the network of hydrogen bonding and aromatic
interactions involving pyrimidine and phenyl rings. Non-covalent inter-
actions involving aromatic rings are key processes in both chemical and
biological recognition, contributing to overall complex stability and
forming recognition motifs. It is noteworthy that in complex 11, π–π
stacking interactions between pairs of antiparallel triazolopyrimidine
rings mimick base-pair interactions physiologically occurring in DNA.
As for the antimicrobial activity, the latter being very active with a
MIC value of 5 μg mL−1 against S. aureus ATCC29213. n-Bu2SnCl2
(dptp) and n-BuSnCl3(dbtp)2 resulted active against methicillin resis-
tant S. epidermidis RP62A, but showed a weak or no activity against
the other strains. Unfortunately, we are forced to conclude that sub-
stitution in the ligands of hydrogen (tp) and methyl (dmtp) with
tert-butyl (dbtp) and phenyl (dptp) groups, affords complexes
whose activity against S. aureus ATCC 25923, exhibit a lower inhibi-
tion against bacteria, which clearly indicates that introduction of ste-
rically hindering organic residues decreases the activity of the parent
organometallic moieties. This notwithstanding, an overall view on the
biological activity of this class of molecules is attractive, and a rational
development of leads including modiﬁed entities, endowed with
more effective antimicrobial properties, according to the basic princi-
ples outlined by Silverman [47], can be pursued.Acknowledgment
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